Data / Form D filings / Centrexion Therapeutics Corp
Centrexion Therapeutics Corp: Form D filings
Centrexion Therapeutics Corp, a biotechnology company in Boston, MA, filed 17 Form D notices with the SEC between 2013 and 2024. The latest, on January 8, 2024, reports $3.3 million sold of a $12.9 million offering to 116 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 STATE STREET, 6TH FLOOR, Boston, MA, 02109
- Phone
- (617) 837-6911
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1592052
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | New notice | $12,859,762 | $3,255,467 | $9,604,295 | 116 | Dec 28, 2023 | sec.gov |
| Nov 27, 2023 | New notice | $2,300,000 | $2,300,000 | 2 | Nov 14, 2023 | sec.gov | |
| Jul 11, 2023 | Amendment | $30,000,000 | $10,280,238 | $19,719,762 | 124 | Jun 14, 2023 | sec.gov |
| Jun 29, 2023 | New notice | $10,280,238 | $10,280,238 | 124 | Jun 14, 2023 | sec.gov | |
| Aug 11, 2022 | Amendment | $29,140,000 | $29,140,000 | 47 | May 24, 2022 | sec.gov | |
| Jun 28, 2022 | Amendment | $23,750,000 | $23,750,000 | 43 | May 24, 2022 | sec.gov | |
| Jun 8, 2022 | New notice | $16,475,000 | $16,475,000 | 25 | May 24, 2022 | sec.gov | |
| Jan 26, 2021 | New notice | $13,500,000 | $13,500,000 | 17 | Jan 12, 2021 | sec.gov | |
| Jan 2, 2018 | New notice | $69,566,532 | $69,566,532 | 67 | Dec 18, 2017 | sec.gov | |
| May 23, 2017 | New notice | Indefinite | $5,285,000 | 40 | Apr 28, 2017 | sec.gov | |
| Jan 5, 2017 | New notice | $16,564,789 | $16,564,789 | 14 | Dec 30, 2016 | sec.gov | |
| Jun 21, 2016 | New notice | Indefinite | $11,163,500 | 61 | Jun 14, 2016 | sec.gov | |
| Apr 15, 2016 | New notice | Indefinite | $6,905,000 | 21 | Apr 8, 2016 | sec.gov | |
| Mar 14, 2016 | New notice | Indefinite | $10,516,500 | 25 | Mar 1, 2016 | sec.gov | |
| Dec 3, 2013 | Amendment | $35,000,000 | $14,728,886 | $20,271,114 | 98 | Nov 20, 2013 | sec.gov |
| Dec 3, 2013 | New notice | $8,750,000 | $8,750,000 | 20 | Nov 20, 2013 | sec.gov | |
| Nov 22, 2013 | New notice | $35,000,000 | $14,728,886 | $20,271,114 | 98 | Nov 20, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shawn R. Tomasello | Director | |
| Michael J. Ward | Executive Officer | |
| James N. Campbell, M.D. | Executive Officer, Director | |
| Sol J. Barer, Ph.D. | Director | |
| Colin J. Hill | Director | |
| Randall M. Stevens | Executive Officer | |
| Joseph R. Swedish | Director | |
| Jeffrey B. Kindler | Executive Officer, Director | |
| J.C. J. Lopez, M.D. | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Centrexion Therapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.